- Report
- March 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- March 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- July 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- November 2025
- 160 Pages
Global
From €4257EUR$4,850USD£3,704GBP
- Report
- October 2025
- 89 Pages
Global
From €4257EUR$4,850USD£3,704GBP
- Report
- October 2025
- 80 Pages
Global
From €4257EUR$4,850USD£3,704GBP
- Report
- October 2025
- 90 Pages
Global
From €4257EUR$4,850USD£3,704GBP
- Report
- October 2025
- 48 Pages
Global
From €1053EUR$1,200USD£916GBP
- Report
- October 2025
- 163 Pages
Global
From €4257EUR$4,850USD£3,704GBP
- Report
- August 2025
- 50 Pages
Global
From €8773EUR$9,995USD£7,633GBP
- Report
- July 2025
- 250 Pages
Global
From €2281EUR$2,599USD£1,985GBP
- Report
- June 2025
- 106 Pages
Global
From €3028EUR$3,450USD£2,635GBP
- Report
- June 2025
- 194 Pages
Global
From €4345EUR$4,950USD£3,780GBP
- Report
- May 2025
- 138 Pages
Global
From €4257EUR$4,850USD£3,704GBP
- Report
- April 2025
- 59 Pages
Global
From €2589EUR$2,950USD£2,253GBP
- Report
- July 2025
- 54 Pages
Europe
From €2853EUR$3,250USD£2,482GBP
- Report
- July 2025
- 51 Pages
Asia Pacific
From €2853EUR$3,250USD£2,482GBP
- Report
- May 2025
- 75 Pages
Asia Pacific
From €2853EUR$3,250USD£2,482GBP
- Report
- May 2025
- 83 Pages
Europe
From €2853EUR$3,250USD£2,482GBP
- Report
- June 2025
- 200 Pages
Europe
From €2186EUR$2,490USD£1,902GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more